MEDI-517P
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI-517P, covering 2009-01-08 to 2009-01-08. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive [Phase 1, Phase 2]